Live Breaking News & Updates on Shenyang Sunshine Pharmaceutical Co Ltd

Stay updated with breaking news from Shenyang sunshine pharmaceutical co ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Analyzing WuXi Biologics (Cayman) (OTCMKTS:WXXWY) and Selecta Biosciences (NASDAQ:SELB)

WuXi Biologics (Cayman) (OTCMKTS:WXXWY – Get Free Report) and Selecta Biosciences (NASDAQ:SELB – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, valuation, earnings, risk and dividends. Analyst Recommendations This is a summary of […] ....

United States , Massachusetts Institute Of Technology , Selecta Bioscience , Selecta Biosciences , Wuxi Biologics Cayman Inc , Asklepios Biopharmaceutical Inc , Biosciences Inc , Takeda Pharmaceuticals United States Inc , Shenyang Sunshine Pharmaceutical Co Ltd , Astellas Therapeutics Inc , Ginkgo Bioworks Holdings Inc , Sarepta Therapeutics Inc , Cyrus Biotechnology Inc , Selecta Biosciences Inc , Wuxi Biologics , Get Free Report , Given Selecta Bioscience , North America , Ginkgo Bioworks Holdings , Cyrus Biotechnology , Astellas Therapeutics , Takeda Pharmaceuticals United States , Swedish Orphan Biovitrum , Sarepta Therapeutics , Asklepios Biopharmaceutical , Massachusetts Institute ,

CStone Announces Strategic Partnership and Exclusive Licensing Agreement with 3SBio for Nofazinlimab (Anti-PD-1 Antibody) in Mainland China

SUZHOU, China, Nov. 1, 2023 /PRNewswire/ CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, ....

United Kingdom , Lou Jing , United States , Jason Yang , National Engineering Research Center , 3sbio Inc , American Society Of Clinical Oncology , European Society For Medical Oncology , World Health Organization , Cstone Pharmaceuticals , Shenyang Sunshine Pharmaceutical Co Ltd , International Agency For Research On Cancer , British Journal , Medical Oncology , Annual Conference , Clinical Oncology , Orphan Drug Designation , Global Cancer Incidence , International Agency , Antibody Medicine , Cherish Life , Nat Rev Clin , Nat Rev Dis , Circulating Tumor Cells , Their Implications , Therapeutic Monitoring ,

China Recombinant Human Thrombopoietin Market Investigation Report 2021-2025

Share this article
Share this article
ResearchAndMarkets.com s offering.
In recent years, the incidence of thrombopenia in China keeps increasing. The number of patients with thrombopenia in China is increasing by over 100,000 every year. Research shows that 20% to 30% of patients receiving chemotherapy have obvious thrombopenia. The incidence of thrombopenia is 81.80% among patients receiving single-agent carboplatin chemotherapy, 58.20% among patients receiving carboplatin combination chemotherapy, 64.40% among patients receiving gemcitabine chemotherapy and 59.30% among patients receiving paclitaxel chemotherapy.
Using thrombopoietin such as Recombinant Human Thrombopoietin is one of the ways to treat thrombopenia. In 2005, Recombinant Human Thrombopoietin by Shenyang Sunshine Pharmaceutical Co., Ltd. (trade name: TPIAO) was approved to be sold in China. By the end of 2020, Shenyang Sunshine Pharmaceutical Co., Ltd. is the only approved Recombinant Human Thromb ....

Laura Wood , E St Office Hours Call , Development Of Recombinant Human Thrombopoietin , Development Of China Recombinant Human Thrombopoietin Market , Office Hours Call , Shenyang Sunshine Pharmaceutical Co Ltd , Development Trend Of Dosage , Recombinant Human Thrombopoietin Market , Recombinant Human Thrombopoietin , Topics Covered , Government Approval , Sales Value , Sales Volume , Dosage Form , Major Manufacturer , Recombinant Human , Influencing Development , Market Opportunities , Market Size , Senior Manager , Free Call , Hours Call , Research And Markets , லாரா மரம் , ஏ ஸ்டம்ப் அலுவலகம் மணி அழைப்பு , அலுவலகம் மணி அழைப்பு ,